S. Bajpai1, A. Khan2, R. Stahl1 1University Of Alabama at Birmingham,Department Of Surgery,Birmingham, Alabama, USA 2Baylor College Of Medicine,Department Of Surgery,Houston, TX, USA
Introduction:
Robotic surgery is increasingly being employed to treat various pathologies. Heineke-Mikulicz pyloroplasty has been shown to be effective and safe option for the treatment of gastroparesis. This study examines the safety and efficacy of robotic Heineke-Mikulicz pyloroplasty at a single institution.
Methods:
A chart review was conducted to identify patients who underwent elective robotic pyloroplasty for gastroparesis from January 2017 to December 2018. Patient demographics, comorbidities, preoperative history, intraoperative details, postoperative complications, and symptom resolution were collected. Descriptive statistics were employed and frequencies were calculated.
Results:
20 patients underwent robotic Heineke-Mikulicz pyloroplasty over the 2-year study period. Most of the patients undergoing surgery had gastroparesis secondary to diabetes (50%) followed by idiopathic (30%) and vagal injury (15%). Eighty-five percent of patients were females. Half of the patients had already undergone gastric stimulator placement.
The mean operative time was 91.8±24 minutes and the mean blood loss was 13.6±13 ml. The only intraoperative complication was a cautery injury to the distal stomach which was over sewn.
Mean postoperative length of stay was 2.8±1 days. 30-day unplanned readmission rate was 25%, with one patient being readmitted for complication related to surgery. There was no 30-day mortality or unplanned return to the operating room.
Mean follow-up time to postoperative clinic visit was 22.6±19 days. At that time, 70% of patients reported at least some improvement in symptoms. Three patients underwent future surgery related to their gastroparesis diagnosis.
Conclusion:
Robotic Heineke-Mikulicz pyloroplasty is a feasible and safe option for patients suffering from gastroparesis with good short-term results.